Dual, tumor-specific TNFR2 and CD47 blockade using an oncolytic virus enhances anticancer immunity June 13, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results